Cancer BiologybioRxivPreprint
Concurrent inhibition of ICMT and RAF/MEK suppresses RAC1P29S-driven MAPKi resistance in BRAFV600E melanoma by regulating TAZ activity
Xiaoyang Gu, Patrick J. Casey, Mei Wang
This study shows that combining ICMT and MAPK inhibitors suppresses RAC1P29S-driven resistance in BRAFV600E melanoma by inhibiting TAZ activity.
DOI 10.1101/2025.08.10.669587